ÖZDAĞ SEVGİLİ, H. Et Al. 2002. Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not In primary tumours. BRITISH JOURNAL OF CANCER , vol.87, no.10 , 1162-1165.

ÖZDAĞ SEVGİLİ, H., Batley, S., Forsti, A., Iyer, N., Daigo, Y., Boutell, J., ... Arends, M.(2002). Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not In primary tumours. BRITISH JOURNAL OF CANCER , vol.87, no.10, 1162-1165.

ÖZDAĞ SEVGİLİ, HİLAL Et Al. "Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not In primary tumours," BRITISH JOURNAL OF CANCER , vol.87, no.10, 1162-1165, 2002

ÖZDAĞ SEVGİLİ, HİLAL Ö. Et Al. "Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not In primary tumours." BRITISH JOURNAL OF CANCER , vol.87, no.10, pp.1162-1165, 2002

ÖZDAĞ SEVGİLİ, H. Et Al. (2002) . "Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not In primary tumours." BRITISH JOURNAL OF CANCER , vol.87, no.10, pp.1162-1165.

@article{article, author={HİLAL ÖZDAĞ SEVGİLİ Et Al. }, title={Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not In primary tumours}, journal={BRITISH JOURNAL OF CANCER}, year=2002, pages={1162-1165} }